MIND Prize Initiative
Forecasted
MIND Prize Initiative supports early-to-mid-career investigators pursuing bold brain research to transform understanding, prediction, prevention, and treatment of neurodegenerative diseases.
Browse similar grants
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2027 (Letter of Intent)
Funding Amounts: $750,000 over three years ($250,000 per year); generally at least six prizes annually
Summary: Supports early-to-mid-career investigators pursuing bold, hypothesis-driven research on brain biology, cognition, and neurodegenerative diseases.
Key Information: Lead investigators must have 1–8 years of independent research experience at a U.S. nonprofit research institution by the award start.
Description
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize is The Pershing Square Foundation’s brain research initiative. It supports early-to-mid-career investigators pursuing scientifically sound, high-risk, high-reward research that could transform understanding, prediction, prevention, and treatment of neurodegenerative diseases. Basic and translational research are supported, with particular emphasis on Alzheimer’s disease, dementias, and related neurocognitive disorders.
The initiative encourages interdisciplinary approaches and collaboration across departments and institutions. Research may involve neurobiology, brain imaging and mapping, machine learning, drug delivery, or synthetic biology. Tool and technology development must test a clearly defined biological hypothesis; screening may contribute to a project but cannot be its sole focus. Clinical components are permitted, but projects centered on clinical trials or medical-device testing in humans are outside the program’s scope.
